RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Designing a drug delivery system for improved tumor treatment and targeting by functionalization of a cell-penetrating peptide

        Shafq Al‑azzawi,Dhafir Masheta 한국약제학회 2019 Journal of Pharmaceutical Investigation Vol.49 No.6

        Antitumor drugs activity is often limited due to the lack of satisfactory tumor specificity and bioavailability. Therefore, it is essential to conjugate the antitumor drug to a specific delivery system that can discriminate between tumors and normal tissue, and potentiate the activity. Purpose: the study was aimed to design a delivery system employing a cell-penetrating peptide, TAT, functionalized with a tumor targeting peptide, CREKA, and loaded with antitumor drug via a biodegradable linkage. Methods: the delivery system was synthesized using solid phase peptide synthesis and characterized by mass spectra and HPLC technique. Confocal microscopy and flow cytometry were used to examine the cellular uptake of the drug conjugate by malignant and normal cells whereas cell viability was tested to assess its cytotoxicity. Inhibition assay on dihydrofolate reductase (DHFR) to study the drug conjugate efficacy, and its stability examination were also performed. Results: characterization results confirmed successful synthesis of the delivery system and its conjugation with the drug. In addition, cellular translocation studies revealed higher cellular uptake of drug conjugate by malignant cell. The results also showed a better efficacy of the drug in conjugation in cytotoxicity and in the inhibition of DHFR and more stability at neutral pH medium. Conclusion: the functionalization with CREKA targeted the delivery of the antitumor drug to the malignant breast cells, decreasing its distribution to the normal cells. Hence this study demonstrated the potential of the designed delivery system to be used in delivering and translocating of therapeutic agents into a specific tumor tissue.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼